pantoprazole has been researched along with ranitidine in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (21.92) | 18.2507 |
2000's | 36 (49.32) | 29.6817 |
2010's | 19 (26.03) | 24.3611 |
2020's | 2 (2.74) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Classen, M; Schepp, W | 1 |
Hotz, J; Plein, K; Rose, K; Schönekäs, H | 1 |
Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C | 1 |
Classen, M; Dammann, HG; Koop, H; Lühmann, R; Schepp, W; Schneider, A | 1 |
Bader, JP; Delchier, JC | 1 |
Brunner, G; Harke, U | 1 |
Judmaier, G; Koelz, HR | 1 |
Lamers, CB | 1 |
Dítĕ, P; Drazná, E; Dufek, V; Dvorák, M; Fric, P; Huslarová, A; Jirásek, V; Kunovská, M; Münzová, H; Pelech, T; Petrtýl, J; Roth, Z; Svoboda, J; Zádorová, Z; Zavoral, M | 1 |
Berstad, A; Hatlebakk, JG | 1 |
Abucar, A; Armbrecht, U; Hameeteman, W; Schneider, A; Stockbrügger, RW | 1 |
Döbrönte, Z; Juhász, L; Lonovics, J; Papp, J | 1 |
Müller, P; Simon, B | 1 |
Hetzel, D | 1 |
Lambert, JR; Treiber, G | 1 |
Dettmer, A; Fischer, R; Lühmann, R; Schneider, A; Sielaff, F; Vogt, R | 1 |
de Paula Castro, L; Lyra, LG; Malafaia, O; Meneghelli, UG; Zaterka, S | 1 |
Bethke, T; de K Grundling, H; Fischer, R; O'Keefe, SJ; Retief, FJ; Theron, I; van Rensburg, CJ; van Zyl, JH | 1 |
Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
Carpio, D; García Grávalos, R; Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
Biedermann, A; Kaspari, S; Mey, J | 1 |
Bardou, M | 1 |
Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
Adamek, RJ; Behrendt, J; Wenzel, C | 1 |
Caro, JJ; Salas, M; Ward, A | 1 |
Almeida, JR; Boaventura, S; Castro, LP; Ferrari, AP; Fischer, R; Haddad, MT; Jorge, JL; Leitão, O; Magalhães, AF; Maguilnik, I; Meneghelli, UG; Moraes-Filho, JP; Silva, E; Tolentino, M | 1 |
Katelaris, P; Moore, MG; Sprogis, A; Talley, NJ | 1 |
Bochenek, WJ; Metz, DC | 1 |
Huggins, RM; Latour, JK; Scates, AC | 1 |
Biagini, R; Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansi, C; Mele, MR; Savarino, V; Tessieri, L; Usai, P; Vigneri, S; Zentilin, P | 1 |
Hiramoto, JS; Norton, JA; Terdiman, JP | 1 |
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
Karamanlioglu, B; Memiş, D; Pamukçu, Z; Saral, P; Turan, A; Türe, M | 1 |
Gandhi, MS; Goswami, SS; Santani, D; Shah, MB; Shah, PJ | 1 |
Fischer, R; van Rensburg, C; van Zyl, J; Vieweg, W | 1 |
Chan, HH; Hsu, PI; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Shie, CB; Tsai, PM; Wang, WM; Wu, CJ; Wu, DC | 1 |
Buzás, GM | 1 |
Allen, DG; Bersenas, AM; Conlon, PD; Mathews, KA | 1 |
Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G | 1 |
Altintaş, E; Sezgin, O; Tataroğlu, C; Uçbilek, E | 1 |
Garcia, I; Krishna, P; Rosen, CA | 1 |
Comer, GM; Jensen, DM; Pace, SC; Soffer, E | 1 |
Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
Buzás, GM; Széles, I | 1 |
Balanzó, J; Barkun, AN; Beglinger, C; Bornman, PC; Devière, J; Doerfler, H; Fedorak, R; Kupcinskas, L; Luehmann, R; Racz, I; Schäfer-Preuss, S; van Rensburg, C | 1 |
Bowton, DL; Houle, TT; Kincaid, EH; MacGregor, DA; Miano, TA; Reichert, MG | 1 |
Dağalp, K; Ilgan, S; Ozgüven, M; Oztürk, E; Yeşilova, Z | 1 |
Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U | 1 |
Andreollo, NA; Coelho Neto, JS; Dragosavac, D; Guerrazzi, F; Montes, CG; Terzi Coelho, CB | 1 |
Chang, CH; Hsu, PI; Huang, YB; Lin, PC; Tseng, PL | 1 |
Haag, S; Holtmann, G | 1 |
Hunt, R; Sachs, G; Shin, JM | 1 |
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
de Rooij, FW; Huisman, EJ; Renooij, W; Siersema, PD; van Erpecum, KJ; van Hoek, B; van Vlerken, LG | 1 |
Bakalli, A; Dragusha, G; Gashi, Z; Joksimovic, N | 1 |
Demetrashvili, ZM; Ekaladze, EN; Kamkamidze, GK; Lashkhi, IM | 1 |
Hilbrands, LB; Kerkhofs, CH; van Boekel, GA; van de Logt, F | 1 |
Gonzalez, B; Guarner, C; Guarner-Argente, C; Juárez, C; Mirelis, B; Monés, J; Nieto, JC; Sánchez, E; Soriano, G; Vidal, S | 1 |
Barbeau, G; Bertrand, OF; De Larochellière, R; Déry, JP; Déry, U; Gleeton, O; Harvey, A; Larose, É; Modak, A; Nguyen, CM; Noël, B; Paradis, JM; Proulx, G; Rinfret, S; Rodés-Cabau, J; Roy, L; Roy, M | 1 |
Fatuzzo, P; Granata, A; Portale, G; Scollo, V; Zanoli, L | 1 |
Cho, JY; Choi, YJ; Jang, IJ; Jo, HJ; Jung, HC; Kim, N; Lee, DH; Nam, RH; Park, JH; Park, YS; Shin, CM; Yoon, H | 1 |
Kline, CM; Ledgerwood, AM; Lucas, CE; Mesquita, WJ; Vernier, P | 1 |
Bilic, Z; Boban Blagaic, A; Brizic, I; Drmic, D; Gojkovic, S; Hriberski, K; Kalogjera, L; Kasnik, K; Knezevic, M; Kokot, A; Kralj, T; Krezic, I; Kubat, M; Lojo, N; Malekinusic, D; Milavic, M; Peklic, M; Seiwerth, S; Sever, M; Sikiric, P; Sikiric, S; Siroglavic, M; Skorak, I; Skrtic, A; Tvrdeic, A; Vladic, J; Vukojevic, J | 1 |
Afzal, NA; Andrews, E; Beattie, RM; Hayen, A; Liddicoat, I; Tighe, MP | 1 |
15 review(s) available for pantoprazole and ranitidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical efficacy of pantoprazole compared with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Duodenal Ulcer; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Stomach Ulcer; Sulfoxides | 1994 |
The changing role of H2-receptor antagonists in acid-related diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Dyspepsia; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1996 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Acid pump inhibitors. The treatment of gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Piperidines; Ranitidine; Sulfoxides | 1998 |
The impact of Helicobacter pylori eradication on peptic ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer; Ranitidine; Stomach Ulcer; Sulfoxides; Treatment Outcome; Wound Healing | 1998 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides | 2001 |
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome | 2001 |
Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cimetidine; Drug Administration Schedule; Enzyme Inhibitors; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides | 2003 |
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Evidence-Based Medicine; Humans; Intensive Care Units; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Postoperative Complications; Ranitidine; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sucralfate; Sulfoxides; Treatment Outcome | 2003 |
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests | 2006 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cimetidine; Critical Care; Histamine H2 Antagonists; Humans; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Risk; Stress, Psychological | 2010 |
Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Humans; Male; Multicenter Studies as Topic; Nizatidine; Pantoprazole; Randomized Controlled Trials as Topic; Ranitidine | 2010 |
Pharmacological treatment of gastro-oesophageal reflux in children.
Topics: Adolescent; Child; Esomeprazole; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine | 2023 |
37 trial(s) available for pantoprazole and ranitidine
Article | Year |
---|---|
Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Treatment Outcome | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides; Time Factors | 1995 |
A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Time Factors | 1995 |
Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1995 |
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Gastrins; Humans; Longitudinal Studies; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides | 1994 |
Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1994 |
[Treatment of duodenal ulcer with pantoprazole. A multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 1996 |
Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1997 |
[Evaluation of the effectiveness of pantoprazole and ranitidine in the treatment of duodenal ulcer. Result of an international multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Humans; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 1997 |
[The action of the proton pump inhibitor pantoprazol against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled, double blind comparison].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1998 |
Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome | 1998 |
Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 2000 |
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Severity of Illness Index; South Africa; Sulfoxides; Treatment Outcome | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Ranitidine; Sulfoxides; Treatment Outcome | 2000 |
Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Gastroesophageal Reflux; Germany; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Sulfoxides; Treatment Outcome | 2001 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides | 2001 |
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Probability; Ranitidine; Risk Assessment; Sulfoxides; Treatment Outcome; Wound Healing | 2002 |
Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome | 2002 |
Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aluminum Hydroxide; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Combinations; Esophagitis; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Recurrence; Silicic Acid; Sulfoxides; Treatment Outcome | 2003 |
Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Reference Values; Risk Assessment; Sensitivity and Specificity; Sulfoxides | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pneumonia, Aspiration; Postoperative Period; Ranitidine; Risk Assessment; Stomach; Sulfoxides | 2003 |
Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Odds Ratio; Omeprazole; Pantoprazole; Placebos; Ranitidine; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2004 |
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Combined Modality Therapy; Female; Hemostasis, Endoscopic; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Prospective Studies; Ranitidine; Secondary Prevention; Sulfoxides | 2004 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Ranitidine; Tetracycline; Treatment Outcome; Urease; Young Adult | 2006 |
Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides; Treatment Outcome; United States | 2006 |
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Urea | 2008 |
Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Humans; Injections, Intravenous; Middle Aged; Pantoprazole; Peptic Ulcer Hemorrhage; Ranitidine; Secondary Prevention; Statistics as Topic; Young Adult | 2009 |
Performance of acidified 14C-urea capsule breath test during pantoprazole and ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Breath Tests; Capsules; Carbon Radioisotopes; Citric Acid; False Negative Reactions; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Time Factors; Treatment Outcome; Urea | 2009 |
Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Ranitidine | 2009 |
Ranitidine is unable to maintain gastric pH levels above 4 in septic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; APACHE; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Pantoprazole; Ranitidine; Sepsis; Time Factors | 2009 |
The efficacy of PPI after endoscopic hemostasis in patients with bleeding peptic ulcer and role of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Hemostasis, Endoscopic; Humans; Male; Middle Aged; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine | 2012 |
Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Intravenous; Adult; Aged; Female; Hemorrhage; Humans; Male; Middle Aged; Pantoprazole; Peptic Ulcer; Ranitidine | 2013 |
Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Blood Platelets; Breath Tests; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Humans; Omeprazole; Pantoprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Ranitidine; Ticlopidine | 2016 |
Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Coronary Syndrome; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ranitidine; Republic of Korea; Single-Blind Method; Ticlopidine | 2017 |
21 other study(ies) available for pantoprazole and ranitidine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Study of Mimusops elengi bark in experimental gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Ethanol; Female; Gastric Acid; Injections, Intraperitoneal; Male; Mimusops; Omeprazole; Pantoprazole; Plant Bark; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Sulfoxides | 2003 |
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cisapride; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Reproducibility of Results; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2004 |
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Famotidine; Food Deprivation; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Reference Values; Sulfoxides | 2005 |
Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Therapy, Combination; Gastroesophageal Reflux; Hoarseness; Humans; Keratosis; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Ranitidine; Respiratory Tract Infections; Sulfoxides | 2006 |
Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Distribution; Aged; Anti-Ulcer Agents; Area Under Curve; Cohort Studies; Confidence Intervals; Cross Infection; Female; Follow-Up Studies; Humans; Incidence; Intensive Care Units; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pantoprazole; Peptic Ulcer; Pneumonia, Ventilator-Associated; Postoperative Complications; Probability; Proportional Hazards Models; Ranitidine; Reference Values; Retrospective Studies; Risk Assessment; Sex Distribution; Statistics, Nonparametric; Thoracic Surgical Procedures; Treatment Outcome | 2009 |
Novel approaches to inhibition of gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Histamine Antagonists; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine | 2010 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Animals; Bacteria; Bacterial Infections; Cohort Studies; Female; Humans; Jejunum; Liver Cirrhosis; Male; Middle Aged; Models, Animal; Netherlands; Omeprazole; Pantoprazole; Peritonitis; Permeability; Polyethylene Glycols; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Risk Factors | 2012 |
Proton pump inhibitors do not increase the risk of acute rejection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Biopsy; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Histamine H2 Antagonists; Humans; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Netherlands; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Ascites; Bacterial Translocation; Blind Loop Syndrome; Gastric Acid; Gastric Mucosa; Gastrointestinal Microbiome; Hydrogen-Ion Concentration; Ileum; Intestinal Mucosa; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Pantoprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2015 |
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; Drug Substitution; Humans; Hypocalcemia; Hypokalemia; Hypoparathyroidism; Magnesium; Male; Pantoprazole; Proton Pump Inhibitors; Pyrrolidonecarboxylic Acid; Ranitidine; Seizures; Treatment Outcome | 2017 |
Failure of gastric prophylaxis against stress bleeding reflects inadequate pH control.
Topics: Adult; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Stress, Physiological | 2018 |
Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pan
Topics: Animals; Arginine; Cytoprotection; Hemorrhage; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Stomach Diseases | 2021 |